These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. The binding characteristics of cholinergic sites in rabbit spermatozoa. Young RJ, Laing JC. Mol Reprod Dev; 1991 Jan; 28(1):55-61. PubMed ID: 1994980 [Abstract] [Full Text] [Related]
7. Muscarinic cholinoceptor regulation of cyclic guanosine monophosphate in human corneal epithelium. Walkenbach RJ, Ye GS. Invest Ophthalmol Vis Sci; 1991 Mar; 32(3):610-5. PubMed ID: 1848211 [Abstract] [Full Text] [Related]
8. In vitro evidence and age-related changes for nicotinic but not muscarinic acetylcholine receptors in the central nervous system of Sepia officinalis. Bellanger C, Halm MP, Dauphin F, Chichery R. Neurosci Lett; 2005 Oct 28; 387(3):162-7. PubMed ID: 16026931 [Abstract] [Full Text] [Related]
9. Heterogeneity of binding sites on cardiac muscarinic receptors induced by the neuromuscular blocking agents gallamine and pancuronium. Dunlap J, Brown JH. Mol Pharmacol; 1983 Jul 28; 24(1):15-22. PubMed ID: 6135150 [Abstract] [Full Text] [Related]
10. Characterization of high affinity [3H]pirenzepine and (-)-[3H] quinuclidinyl benzilate binding to muscarinic cholinergic receptors in rabbit peripheral lung. Bloom JW, Halonen M, Lawrence LJ, Rould E, Seaver NA, Yamamura HI. J Pharmacol Exp Ther; 1987 Jan 28; 240(1):51-8. PubMed ID: 3806397 [Abstract] [Full Text] [Related]
11. Characterization of nicotine binding in mouse brain and comparison with the binding of alpha-bungarotoxin and quinuclidinyl benzilate. Marks MJ, Collins AC. Mol Pharmacol; 1982 Nov 28; 22(3):554-64. PubMed ID: 7155123 [Abstract] [Full Text] [Related]
12. Influences on the density of beta-adrenergic receptors in the cornea and iris--ciliary body of the rabbit. Neufeld AH, Zawistowski KA, Page ED, Bromberg BB. Invest Ophthalmol Vis Sci; 1978 Nov 28; 17(11):1069-75. PubMed ID: 212382 [Abstract] [Full Text] [Related]
14. Direct binding and functional studies on muscarinic cholinoceptors in porcine coronary artery. Yamada S, Yamazawa T, Nakayama K. J Pharmacol Exp Ther; 1990 Feb 28; 252(2):765-9. PubMed ID: 2313599 [Abstract] [Full Text] [Related]
15. Characterization of [3H]pirenzepine binding to muscarinic cholinergic receptors solubilized from rat brain. Luthin GR, Wolfe BB. J Pharmacol Exp Ther; 1985 Jul 28; 234(1):37-44. PubMed ID: 3839265 [Abstract] [Full Text] [Related]
16. Comparison of [3H]pirenzepine and [3H]quinuclidinylbenzilate binding to muscarinic cholinergic receptors in rat brain. Luthin GR, Wolfe BB. J Pharmacol Exp Ther; 1984 Mar 28; 228(3):648-55. PubMed ID: 6546770 [Abstract] [Full Text] [Related]
17. Distribution of [3H]quinuclidinyl benzilate, [3H]nicotine, and [125I]alpha-bungarotoxin binding sites in the nucleus tractus solitarii of the cat. Maley BE, Seybold VS. J Comp Neurol; 1993 Jan 08; 327(2):194-204. PubMed ID: 8425941 [Abstract] [Full Text] [Related]
18. Evidence for muscarinic cholinergic receptors in dog portal vein: binding of [3H]quinuclidinyl benzilate. Taniguchi T, Tsukahara T, Fujiwara M. Life Sci; 1983 Apr 11; 32(15):1757-63. PubMed ID: 6835022 [Abstract] [Full Text] [Related]
19. Identification and characterization of muscarinic cholinergic receptors in the isolated plasma membranes and intact tissue of the urinary bladder. Batra S. J Recept Res; 1986 Apr 11; 6(3-4):227-46. PubMed ID: 3806496 [Abstract] [Full Text] [Related]
20. Pharmacological differences between the high-affinity muscarinic agonist binding states of the rat heart and cerebral cortex labeled with (+)-[3H]cismethyldioxolane. Vickroy TW, Roeske WR, Yamamura HI. J Pharmacol Exp Ther; 1984 Jun 11; 229(3):747-55. PubMed ID: 6202869 [Abstract] [Full Text] [Related] Page: [Next] [New Search]